Sign in
CompletedNo phase

Bone Marrow Cells With Core Decompression for AVN Treatment

Key facts

Who runs it
Global Stem Cell Center, Baghdad
Where
Iraq1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
10 people enrolled
Started
10 Aug 2023
Ended
28 Jul 2024
Type of study
Interventional
Treatments tested
  • core decompression with local bone marrow mononuclear cells injection
Record updated
30 July 2024

Who can take part

Age
25 years to 55 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Avascular hip necrosis irrespective Of stage
  • age from 25-55 years. -

Who cannot take part

  • history of bleeding tendency
  • history of malignant disease
  • critically ill patient. -

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Avascular necrosis of the femoral head (AVN) is a progressive pathological process resulting from disruption of blood supply to the femoral head and elevation of intraosseous pressure. total hip arthroplasty is frequently the only durable option for pain relief and restoration of function. this is a single armed study to be done from July 2023 till January 2024, the total number of patients anticipated is 10, total joints treated around 20, The procedure includes core decompression with autologous bone marrow derived mononuclear cell injection inside the femoral head using local anesthesia ultrasound and fluoroscopy guided without drilling.

The group in the trial

  • bone marrow injectionOther group

    injection of autologous concentrated bone marrow cells under ultrasound and fluoroscopy guide after core decompression

    Treatment: core decompression with local bone marrow mononuclear cells injection

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Percutaneous Autologous Bone Marrow Cells With Core Decompression for Treating Avascular Hip Necrosis Under Local Anesthesia
Record updated
30 July 2024